...
首页> 外文期刊>International Journal of Pharmaceutics >Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology
【24h】

Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology

机译:使用基于颗粒的前体体技术产生的脂质体的喷气和振动筛网雾化

获取原文
获取原文并翻译 | 示例
           

摘要

The aerosol properties of niosomes were studied using Aeroneb Pro and Omron MicroAir vibrating-mesh nebulizers and Pari LC Sprint air-jet nebulizer. Proniosomes were prepared by coating sucrose particles with Span 60 (sorbitan monostearate), cholesterol and beclometasone dipropionate (BDP) (1:1:0.1). Nano-sized niosomes were produced by manual shaking of the proniosomes in deionized water followed by sonication (median size 236 nm). The entrapment of BDP in proniosome-derived niosomes was higher than that in conventional thin film-made niosomes, being 36.4% and 27.5% respectively. All nebulizers generated aerosols with very high drug output, which was 83.6% using the Aeroneb Pro, 85.5% using the Pari and 72.4% using the Omron. The median droplet size was 3.32 ??m, 3.06 ??m and 4.86 ??m for the Aeroneb Pro, Pari and Omron nebulizers respectively and the "fine particle fraction" (FPF) of BDP was respectively 68.7%, 76.2% and 42.1%. The predicted extrathoracic deposition, based on size distribution of nebulized droplets was negligible for all devices, suggesting all of them are potentially suitable for pulmonary delivery of niosomes. The predicted drug deposition in the alveolar region was low using the Omron (3.2%), but greater using the Aeroneb Pro (17.4%) and the Pari (20.5%). Overall, noisome-BDP aerosols with high drug output and FPF can be generated from proniosomes and delivered using vibrating-mesh or air-jet nebulizers. ? 2013 Elsevier B.V. All rights reserved.
机译:使用Aeroneb Pro和Omron MicroAir振动筛网雾化器以及Pari LC Sprint喷气雾化器研究了脂质体的气溶胶特性。通过用Span 60(脱水山梨糖醇单硬脂酸酯),胆固醇和倍氯米松二丙酸酯(BDP)(1:1:0.1)包被蔗糖颗粒来制备原核小体。纳米大小的脂质体是通过在去离子水中手动摇晃子粒体,然后进行超声处理(中值粒径236 nm)而产生的。原生质体来源的脂质体中BDP的包埋率高于常规薄膜制备的脂质体,分别为36.4%和27.5%。所有雾化器都产生了具有很高药物输出的气雾剂,使用Aeroneb Pro达到83.6%,使用Pari达到85.5%,使用欧姆龙达到72.4%。 Aeroneb Pro,Pari和Omron雾化器的中值液滴尺寸分别为3.32?m,3.06?m和4.86?m,BDP的“细颗粒分数”(FPF)分别为68.7%,76.2%和42.1。 %。基于雾化液滴大小分布的预测胸外沉积对于所有装置而言都是微不足道的,这表明所有这些装置均潜在地适用于肺部递送脂质体。使用欧姆龙(3.2%)预测的在肺泡区域的药物沉积较低,而使用Aeroneb Pro(17.4%)和Pari(20.5%)则更高。总体而言,具有高药物输出和FPF的Nonosome-BDP气溶胶可以从前质体中产生,并使用振动筛网或喷气雾化器输送。 ? 2013 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号